5'H-PREGNA-1,4-DIENO(17,16-D)OXAZOLE-3,20-DIONE, 11,21-BIS(ACETYLOXY)-2'-METHYL-, (11.BETA.,16.BETA.)-
UNII LK3AP6Q5PX
Substance Identification & Data
This profile provides standardized clinical and technical data for 5'h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione, 11,21-bis(acetyloxy)-2'-methyl-, (11.beta.,16.beta.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LK3AP6Q5PX.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 710951-92-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H33NO7 FQQKLFSLSCOADB-NBZCPFCYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5'h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione, 11,21-bis(acetyloxy)-2'-methyl-, (11.beta.,16.beta.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.